META Pharmaceuticals Inc. is a VC-backed early-stage company that is utilizing the power of metabolism to modulate the immune system to treat various diseases, including broad rages of autoimmune diseases and cancer. META is in close collaboration with XtalPI, the leader in the AI-powered drug design field, to co-develop first-in-class drugs that can potentially help hundreds of millions of patients who suffer from autoimmune diseases and cancer physically and psychologically.